Robert L Humble, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2516 Broadmoor Blvd, Monroe, LA 71201 Phone: 318-807-1390 Fax: 318-807-1394 |
Dr. Arthur E Liles, MD Urology Medicare: Medicare Enrolled Practice Location: 2516 Broadmoor Blvd, Monroe, LA 71201 Phone: 318-387-9420 Fax: 318-323-8216 |
Dr. Jon Bradley Johnson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2516 Broadmoor Blvd, Monroe, LA 71201 Phone: 318-387-9420 Fax: 318-323-8216 |
Dr. Don F Marx, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 3510 Magnolia Cv, Suite 170, Monroe, LA 71203 Phone: 318-387-9774 Fax: 318-322-7306 |
Dr. John Michael Cage, MD Urology Medicare: Medicare Enrolled Practice Location: 312 Grammont St Ste 411, Monroe, LA 71201 Phone: 318-966-6622 Fax: 318-966-6621 |
Kenneth L Perego, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 601 Keyser Ave, Natchitoches, LA 71457 Phone: 318-214-5770 |
Dr. Clyde R Roy Iii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 602 N Lewis St, Suite 400, New Iberia, LA 70563 Phone: 337-365-4113 Fax: 307-365-4115 |
Carrie Aline Stewart, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, New Orleans, LA 70112 Phone: 256-658-1406 |
Dr. Harold A Fuselier, MD Urology Medicare: Medicare Enrolled Practice Location: 2820 Napoleon Ave, Suite 890, New Orleans, LA 70115 Phone: 504-412-1366 Fax: 504-412-1367 |
Dr. Nathan Samuel Wexler, M.D. Urology Medicare: Medicare Enrolled Practice Location: 6050 Annunciation St, New Orleans, LA 70118 Phone: 504-897-3088 Fax: 504-891-1326 |
Dr. David C Benson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2000 Canal St Fl 5, New Orleans, LA 70112 Phone: 504-702-4333 |
Dr. Raju Thomas, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave, Urology Clinic, New Orleans, LA 70112 Phone: 504-988-2300 Fax: 504-988-7655 |
Louis Spencer Krane, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-2750 |
Dr. Aaron D Martin, M.D., M.P.H Urology Medicare: Accepting Medicare Assignments Practice Location: 200 Henry Clay Ave, New Orleans, LA 70118 Phone: 504-896-9233 Fax: 504-896-9861 |
Dr. Ronald S. Swartz, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3434 Prytania St., Suite 450, New Orleans, LA 70115 Phone: 504-897-7711 Fax: 504-897-7998 |
Ayad Abed Yousif, Urology Medicare: Not Enrolled in Medicare Practice Location: 1415 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-5615 |
Dr. Colin M Goudelocke, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4083 Fax: 504-842-6271 |
Dr. Christopher Charles Roth, M.D. Urology - Pediatric Urology Medicare: Accepting Medicare Assignments Practice Location: 200 Henry Clay Ave, New Orleans, LA 70118 Phone: 504-896-9233 Fax: 504-896-9861 |
Dr. Erik Peter Castle, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave Fl 3, New Orleans, LA 70112 Phone: 504-988-5271 Fax: 504-988-7655 |
Frank R Cerniglia Jr., M.D. Urology Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4083 |
News Archive
A new study found a relationship between sleep duration and suicidal thoughts in people with insomnia.
Speaking today at the plenary session of the 7th Annual European Antibody Congress in Geneva, Dr. Anat Cohen-Dayag, President and CEO of Compugen Ltd., presented Compugen's Antibody Target Discovery Platform, one of the Company's predictive discovery platforms for novel therapeutic targets.
A novel concept for the treatment of mitochondrial disorders using directed enzyme replacement therapy (DERT) has won for a Hebrew University of Jerusalem doctoral candidate one of this year's Kaye Innovation Awards. The awards were presented at this year's 71st meeting of the Hebrew University Board of Governors.
In a study that included more than 56,000 patients with inflammatory bowel disease, use of a popular class of medications known as tumor necrosis factor alpha antagonists was not associated with an increased risk of cancer over a median follow-up of 3.7 years, although an increased risk of malignancy in the long term, or with increasing number of doses, cannot be excluded, according to a study in the June 18 issue of JAMA.
› Verified 9 days ago